Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046317 · ClinicalTrials.gov registry record · Phase 4
Trial of Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT02046317 is a Phase 4 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 12 participants.
The verdict
NCT02046317, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study aims to determine if there is any difference in the success rate of ultra-sound guided femoral nerve block performed with an echogenic needle versus a standard needle.
Interventions
- DEVICE Ultrasound
- DRUG Femoral Nerve Block
- DEVICE Echogenic needle
- DEVICE Standard of care needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-05 |
| Est. Completion | 2016-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02046317
The ClinicalTrials.gov registry entry for NCT02046317 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ultrasound is the first listed.
NCT02046317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02046317 about?
NCT02046317 is a clinical study titled "Trial of Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles". This study aims to determine if there is any difference in the success rate of ultra-sound guided femoral nerve block performed with an echogenic needle versus a standard needle.
What is the current status of trial NCT02046317?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2011-05. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02046317?
The interventions under investigation include: Ultrasound (DEVICE), Femoral Nerve Block (DRUG), Echogenic needle (DEVICE), Standard of care needle (DEVICE).
Who is sponsoring clinical trial NCT02046317?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.